The Lupus Foundation of America (LFA) celebrated exceptional lupus researchers at the 20th Anniversary Evelyn V. Hess ...

The current recommended urine protein to creatinine ratio is arbitrary, and a lower bar would capture more lupus nephritis ...

Investigators from Hospital for Special Surgery (HSS) presented provocative evidence showing how social determinants of ...

Climb Bio, Inc. (($CLYM)) announced an update on their ongoing clinical study. Study Overview: Climb Bio, Inc. is conducting a Phase 1b study ...

BMS Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus ...

Biogen Inc. (($BIIB)) announced an update on their ongoing clinical study. Study Overview: Biogen Inc. is conducting a Phase 3 clinical study ...

KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid ...

Cabaletta Bio shares gained after the company shared positive clinical data about its trials for treatment of multiple autoimmune diseases. The stock rose 13% to $2.79. Shares are up 23% this year.

Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 - WALTHAM, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Zenas ...

KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to appro ...

Fibromyalgia was considered a comorbidity rather than a rheumatic disease, but was present in about 10% of patients. Other ...

Selena Gomez is once again in the spotlight, but this time not for her music or her personal life. In the music video for her ...